19-41756923-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002483.7(CEACAM6):āc.388G>Cā(p.Val130Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000378 in 1,613,028 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002483.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CEACAM6 | NM_002483.7 | c.388G>C | p.Val130Leu | missense_variant | 2/6 | ENST00000199764.7 | |
LOC112268252 | XR_002958447.2 | n.1494C>G | non_coding_transcript_exon_variant | 2/2 | |||
CEACAM6 | XM_011526990.3 | c.388G>C | p.Val130Leu | missense_variant | 2/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CEACAM6 | ENST00000199764.7 | c.388G>C | p.Val130Leu | missense_variant | 2/6 | 1 | NM_002483.7 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152160Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 250298Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135224
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1460868Hom.: 0 Cov.: 33 AF XY: 0.0000289 AC XY: 21AN XY: 726674
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152160Hom.: 0 Cov.: 31 AF XY: 0.0000404 AC XY: 3AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 05, 2023 | The c.388G>C (p.V130L) alteration is located in exon 2 (coding exon 2) of the CEACAM6 gene. This alteration results from a G to C substitution at nucleotide position 388, causing the valine (V) at amino acid position 130 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at